Adial Pharmaceuticals (NASDAQ: ADIL) is gaining 37% in pre-open trade after the company announced plans to expand activities around ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Momentum Movers Trader Talk

Adial Pharmaceuticals (ADIL) Bullish View Reiterated at Maxim Group Following Lead Asset ExpansionDecember 13, 2018 12:27 PM Adial Pharmaceuticals (ADIL) Halted on LUDPDecember 13, 2018 10:55 AM Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as FentanylDecember 13, 2018 8:00 AM